Cargando…
Presepsin (soluble CD14 subtype) as a risk factor for the development of infectious and inflammatory complications in operated colorectal cancer patients
PURPOSE: In this pilot study the dynamic of presepsin (soluble CD14 subtype, sCD14-ST) in blood serum was assessed as a possible risk factor for the development of systemic inflammatory response syndrome (SIRS) and infectious and inflammatory complications in operated colorectal cancer patients. MET...
Autores principales: | Shakeyev, Kayrat, Turgunov, Yermek, Ogizbayeva, Alina, Avdiyenko, Olga, Mugazov, Miras, Grigolashvili, Sofiko, Azizov, Ilya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Coloproctology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816556/ https://www.ncbi.nlm.nih.gov/pubmed/35368178 http://dx.doi.org/10.3393/ac.2022.00115.0016 |
Ejemplares similares
-
The sCD14-ST predictive value in the development of adverse outcomes in operated colorectal cancer patients (diagnostic study)
por: Turgunov, Yermek, et al.
Publicado: (2023) -
Lipopolysaccharide-binding protein as a risk factor for development of infectious and inflammatory postsurgical complications in colorectal cancer paients
por: Turgunov, Yermek, et al.
Publicado: (2021) -
The Role of Presepsin in Patients with Acute Surgical Diseases
por: Mugazov, Miras, et al.
Publicado: (2019) -
Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2012) -
Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2011)